DAVID MOHLER

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for the Public Health Social Services Emergency Fund (PHSSEF)- Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield; Education and awareness related to therapeutics for prevention or treatment of serious viral diseases.

Reauthorization of the Pandemic and All-Hazards Preparedness Act, legislative and regulatory issues related to vaccine and diagnostic research, development and stockpiling. LHHS preparedness appropriations.

Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for pandemic influenza in the LHHS Appropriations bill.

Legislatives issues related to biodefense preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill.

General health care coverage and reimbursement for prescription drugs; drug pricing reform and related issues; and the Food and Drug Administration legislative and regulatory issues.

General health care coverage and reimbursement for prescription drugs; drug pricing reform; and the Food and Drug Administration legislative and regulatory issues. Legislatives issues related to pandemic preparedness and response, and the reauthorization of the Pandemic and All-Hazards Preparedness Act.

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

INVIVYD, INC.

BAVARIAN NORDIC INC.

LONGHORN

INVIVYD, INC.

GLAXOSMITHKLINE

SEQIRUS

GLAXOSMITHKLINE

SEQIRUS

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

INVIVYD, INC.

LONGHORN